Curriculum Vitae

Dr. GHERLAN George Sebastian

Date personale

 

Nume

GHERLAN George Sebastian

Adresa de contact

Fundatia "Dr. Victor Babes", Sos. Mihai Bravu nr. 281, Sector 3, Bucuresti

Telefon

021/317.95.03

E-mail

gherlanus@gmail.com

Nationalitate

Romana

Data nasterii

19 Ianuarie 1976

Genul

Masculin

Experienta profesionala

 

Perioada

2016 - prezent

Functia sau postul ocupat

Medic primar Boli infectioase

Principalele activitati si responsabilitati

Diagnostic, tratamentul pacientilor; coordonare sectie clinica

Numele si adresa angajatorului

Spitalul Clinic de Boli Infectioase si Tropicale "Dr. Victor Babes", Sos. Mihai Bravu nr. 281, sector 3, Bucuresti

Tipul activitatii sau sectorul de activitate

Medical

Perioada

2016 - prezent

Functia sau postul ocupat

Asistent universitar, Sef de Lucrari

Principalele activitati si responsabilitati

Educatie, Cercetare

Numele si adresa angajatorului

Universitatea de Medicina si Farmacie "Carol Davila", Str. Dionisie Lupu, nr. 37, Sector 1, Bucuresti

Tipul activitatii sau sectorul de activitate

Medical / Educatie medicala

Perioada

2014 - 2015

Functia sau postul ocupat

Director medical

Principalele activitati si responsabilitati

Coordonarea activitatii medicale; Controlul calitatii si asigurarea calitatii activitatii medicale

Numele si adresa angajatorului

Centrul medical "Columna", Clinica de fertilizare in vitro

Tipul activitatii sau sectorul de activitate

Medical

Perioada

2009 - prezent

Functia sau postul ocupat

Medic Specialist / Primar Boli infectioase

Principalele activitati si responsabilitati

Diagnostic, tratamentul pacientilor; cercetare : Studii clinice - subinvestigator / coordonator de studiu / investigator principal

Numele si adresa angajatorului

Centrul de Diagnostic si Tratament "Dr. Victor Babes” (Fundatia "Dr. Victor Babes"), Sos. Mihai Bravu nr. 281, sector 3, Bucuresti

Tipul activitatii sau sectorul de activitate

Medical

Perioada

2006 - 2009

Functia sau postul ocupat

Medic specialist Boli infectioase

Principalele activitati si responsabilitati

Diagnostic, tratamentul pacientilor

Numele si adresa angajatorului

Spitalul Clinic de Boli Infectioase si Tropicale "Dr. Victor Babes", Sos. Mihai Bravu nr. 281, sector 3, Bucuresti

Tipul activitatii sau sectorul de activitate

Medical

Perioada

2002 - 2006

Functia sau postul ocupat

Medic rezident Boli infectioase

Principalele activitati si responsabilitati

Diagnostic, tratamentul pacientilor

Numele si adresa angajatorului

Spitalul Universitar de Urgenta Bucuresti, Splaiul Independentei nr. 169

Tipul activitatii sau sectorul de activitate

Medical

Perioada

2001 - 2002

Functia sau postul ocupat

Medic stagiar (stagiatura 6 luni Medicina Interna, 6 luni Chirurgie generala)

Principalele activitati si responsabilitati

Diagnostic, tratamentul pacientilor

Numele si adresa angajatorului

Spitalul de Urgenta Petrosani

Tipul activitatii sau sectorul de activitate

Medical

Educatie si formare

 

Perioada

25 - 29 Septembrie 2016

Tipul calificarii

ESCMID Curs de invatamant postuniversitar : Bolile infectioase la femeia insarcinata, fat si nou-nascut.

Domeniul

Bolile infectioase la femeia insarcinata, fat si nou-nascut.

Numele si tipul institutiei de invatamant

European Society of Clinical Microbiology and Infectious Diseases

Perioada

29 Mai – 04 Iunie 2016

Tipul calificarii

Salzburg Seminar Medical - sub egida Weill Cornell Medical College New York

Domeniul

Boli infectioase

Numele si tipul institutiei de invatamant

American Austrian Foundation

Perioada

29 - 30 Martie 2014

Tipul calificarii

Elastografie, Doppler vascular, Contrast - ElastoDoppCont

Domeniul

Instruire teoretica ecografie / instruire practica ecografie

Numele si tipul institutiei de invatamant

Asociatia Romana pentru Studiul Ultrasonografiei Clinice si Aplicative - A.R.S.U.S.

Perioada

25 Martie 2014

Tipul calificarii

Certificat de finalizare - Good Clinical Practice (GCP)

Domeniul

Instruire pentru bune practici clinice (GCP) (reinstruire - ultima actualizare)

Numele si tipul institutiei de invatamant

Quintiles Romania

Perioada

15 - 16 Februarie 2014

Tipul calificarii

Absolvent al cursului de ecografie teoretica si practica - Scoala EUROSON 2014. Cursuri practice de CEUS, ecografie gastrointestinala si hepatica

Domeniul

Ecografie : instruire teoretica si practica

Numele si tipul institutiei de invatamant

Hellenic Society for Ultrasound in Medicine / EFSUMB

Perioada

26 - 27 Aprilie 2013

Tipul calificarii

Ecografie hepatica

Domeniul

Ecografie hepatica : instruire teoretica si practica

Numele si tipul institutiei de invatamant

European Association for the Study of the Liver (EASL)

Perioada

2013

Tipul calificarii

Doctor in stiinte medicale

Domeniul

Teza : "Evaluarea noninvaziva a fibrozei, activitatii inflamatoriisi steatozei hepatice in hepatitele virale cronice B si C"

Numele si tipul institutiei de invatamant

Universitatea de Medicina si Farmacie "Carol Davila", Str. Dionisie Lupu, nr. 37, Sector 1, Bucuresti, Catedra de Boli Infectioase

Perioada

05 - 11 Iunie 2011

Tipul calificarii

Salzburg Medical Seminar - sub egida Weill Cornell Medical College New York

Domeniul

Boli infectioase

Numele si tipul institutiei de invatamant

American Austrian Foundation

Perioada

2010

Tipul calificarii

Absolvent Curs de ecografie cu substanta de contrast si Elastografie in timp real (ARFI)

Domeniul

Contrast Enhanced Ultrasound (CEUS)

Numele si tipul institutiei de invatamant

Universitatea de Medicina si Farmacie "Iuliu Hatieganu", Str. Victor Babes nr. 8, Cluj Napoca

Perioada

2009 - 2010

Tipul calificarii

Certificat de absolvire ultrasonografie

Domeniul

Ultrasonografie - practica si teorie

Numele si tipul institutiei de invatamant

Universitatea de Medicina si Farmacie "Carol Davila", Str. Dionisie Lupu, nr. 37, Sector 1, Bucuresti

Perioada

2009 - 2013

Tipul calificarii

Studii doctorale Boli infectioase - Tema : "Evaluarea noninvaziva a fibrozei, activitatii inflamatoriisi steatozei hepatice in hepatitele virale cronice B si C"

Domeniul

Evaluarea noninvaziva a fibrozei hepatice

Numele si tipul institutiei de invatamant

Universitatea de Medicina si Farmacie "Carol Davila", Str. Dionisie Lupu, nr. 37, Sector 1, Bucuresti

Perioada

2008

Tipul calificarii

Absolvent curs Fibroscan

Domeniul

Elastografie tranzitorie

Numele si tipul institutiei de invatamant

Sub supravegherea Echosens Paris (instruire la fata locului)

Perioada

2001 - 2006

Tipul calificarii

Stagiu de specializare in Boli Infectioase

Domeniul

Diagnostic, tratamentul pacientilor

Numele si tipul institutiei de invatamant

Universitatea de Medicina si Farmacie "Carol Davila", Str. Dionisie Lupu, nr. 37, Sector 1, Bucuresti

Nivel in clasificarea nationala sau internationala

Medic specialist Boli infectioase

Perioada

1994 - 2000

Tipul calificarii

Diploma de Doctor - Medic

Domeniul

Formare in domeniul medical - Medicina generala

Numele si tipul institutiei de invatamant

Universitatea de Medicina si Farmacie "Iuliu Hatieganu", Str. Victor Babes nr. 8, Cluj Napoca

Nivel in clasificarea nationala sau internationala

MD

Activitate stiintifica

 

Lista lucrari prezentate la manifestari stiintifice internationale / nationale

  • INFLUENCE OF ESTROGENIC RECEPTOR GENE (ERα) ON THE CLINICAL EVOLUTION OF HCV POSITIVE PATIENTS.
    Laura Raduta, Casandra Ciutacu, Anamaria Botezatu, G. Gherlan, R. Botgros, C.P. Popescu, P. Calistru, D. Olteanu
    15TH National Congress of Hepatology, Bucharest 2005.
  • EPIDEMIOLOGY OF ACCUTE INTOXICATION IN CHIILDREN BETWEEN 1996 - 2005.
    C. Ulmeanu, Viorela Girnita, Madalina Petran, G. Gherlan
    International Congress of Toxicology, 11th edition, Roma, 2006.
  • PARACLINICAL ASPECTS IN C VIRAL HEPATITIS AT ANTIVIRAL TREATMENT INITIATION.
    G. Gherlan, S. Lazar, P. Ionescu, G. Tirdei, G. Cozma, R. Rusu, A. Motoc, P. Calistru
    A IV-a editie a Conferintei Nationale de Boli Infectioase, Iasi 2008.
  • DIARRHEIC DISEASE IN CHILDREN – CLINICAL AND AETHIOLOGIC PARTICULARITIES.
    Geta Cozma, S. Lazar, G. Gherlan, P. Calistru
    Management Medical Modern în domeniul bolilor infecţioase, Bucuresti, 2008.
  • LIVER FIBROSIS EVALUATION BY NONINVASIVE MEANS AT THE BEGINNING OF HCV HEPATITIS TREATMENT AND AFTER TREATMENT.
    G. Gherlan, M. Neata, A. Kosa, P. Calistru
    POSTER PRESENTATION at the EASL Monothematic Conference Evaluation of Disease Severity and Prognosis in Chronic Liver Disease, Nice, January 28 - 29, 2011 (Young Investigator Award).
  • AGREEMENT AND DISAGREEMENT BETWEEN TWO MOST VALIDATED NONINVASIVE FIBROSIS EVALUATION.
    G. Gherlan, M. Neata, P. Calistru, C. Voinea, C. Szabo
    POSTER PRESENTATION at the EASL Monothematic Conference : Liver Fibrogenesis : Common and Organ Specific Mechanisms, Petersberg, Germany from June 17 - 18, 2011.
  • CURRENT NONINVASIVE METHODS FOR LIVER FIBROSIS EVALUATION – AGREEMENT AND DISAGREEMENT IN CHRONIC HEPATITIS B AND C.
    G. Gherlan, P. Calistru, M. Neata, C. Voinea, C. Szabo
    8th STC of APASL with theme "Translational Medicine : Clinical Immunology and Immunotherapy for Viral Hepatitis", 7 - 9 October 2011 in Beijing.
  • THE INFLUENCE OF INFLAMMATION ON LIVER STIFFNESS - A STUDY IN ACUTE HEPATITIS.
    G. Gherlan, S. Lazar, C. Oprea, C. Popescu, V. Melinte, C. Apostol, S.A. Florescu, P. Calistru, E. Ceausu
    ECCMID 2012 Congress in London, United Kingdom, 31 March – 3 April 2012.
  • TRANSIENT ELASTOGRAPHY (FIBROSCAN®) - THE NORMAL VARIABILITY BETWEEN TWO MEASUREMENTS.
    G. Gherlan, P. Calistru, S. Lazar, M. Neata
    International Liver Congress 2012 by EASL, in Barcelona, Spain, April 18-22, 2012. JOURNAL OF HEPATOLOGY, VOL 56, SUPPL, ISSN 0168-8278.
  • MONITORING THE RESULTS OF CHRONIC HEPATITIS C TREATMENT BY NONIVASIVE METHODS.
    G. Gherlan, M. Neata, A. Kosa, P. Calistru
    EASL Special Conference 2012 - Therapy of Hepatitis C: Clinical Aplication and Drug Development, September 10 - 13, 2012 in Prague, Czech Repulic.
  • HOW CAN WE OBTAIN FIBROSIS OUT OF LIVER STIFFNESS AND BIOCHEMICAL TESTS ?
    G. Gherlan, P. Calistru, M. Neata, C. Voinea, C. Szabo
    XVIII Annual Russian Congress "Hepatology Today", March 25 - 27 in Moscow, Russia.
  • LIVER BIOPSY, IMAGING AND BIOCHEMICAL SCORES - THE INVASIVE / NONINVASIVE AGREEMENT.
    G. Gherlan, P. Calistru, C. Voinea, C. Szabo
    International Liver Congres 2013 in Amsterdam (The Netherlands) April 24 - 28, 2013, JOURNAL OF HEPATOLOGY, VOL 58, SUPPL, ISSN 0168-8278.
  • MONITORIZAREA EVOLUTIEI FIBROZEI IN HEPATITELE CRONICE CU VIRUS C PRIN METODE NEINVAZIVE IMAGISTICE SI BIOCHIMICE.
    G. Gherlan, P. Calistru, S. Lazar, M. Neata
    Conferinta Nationala de Boli Infectioase, Timisoara, 9 - 11 Mai 2013.
  • LIVER STIFFNESS IN ACUTE HEPATITIS - NOT ALL THAT'S STIFF IS FIBROSIS.
    G. Gherlan, S. Lazar, C. Oprea, C. Popescu, V. Melinte, C. Apostol, S.A. Florescu, E. Ceausu, P. Calistru
    The 23rd Conference of the Asian Pacific Association on the Study of Liver, Singapore 6th - 10th June 2013 (Young Investigator Award). Hepatology Int, Vol 7, Issue 1, ISSN 1936-0533.
  • ACOUSTIC RADIATION FORCE IMPULSE (ARFI) IN HEPATITIS B VIRUS INACTIVE CARRIERS - A COMPARISON WITH OTHER CONDITIONS.
    G. Gherlan, C. Voinea, C. Szabo, P. Calistru
    EASL Special Conference on "Optimal Management of Hepatitis B Virus Infection", Athens 25 - 27 September 2014, DOI: 10.13140/2.1.4178.8162.
  • ARFI ELASTOGRAPHY – HOW MANY MEASUREMENTS ARE NEEDED FOR THE BEST PERFORMANCE ?
    G. Gherlan, P. Calistru
    EASL Special Conference on "Optimal Management of Hepatitis B Virus Infection", Athens 25 - 27 September 2014, DOI: 10.13140/2.1.4342.6567.
  • COMBINED (IMAGING AND SERIC) NONINVASIVE SCORE FOR PREDICITING SIGNIFICANT LIVER FIBROSIS IN CHRONIC HEPATITIS C.
    G. Gherlan, C. Szabo, C. Voinea, P. Calistru
    APASL 24th conference, Istanbul 12 - 15 March 2015, DOI: 10.13140/RG.2.1.2562.7681.
  • ACOUSTIC RADIATION FORCE IMPULSE IMAGING - THE "NORMAL" VARIABILITY BETWEEN TWO MEASUREMENTS.
    G. Gherlan, M. Neata, A. Kosa, P. Calistru
    APASL 24th conference, Istanbul 12 - 15 March 2015, DOI: 10.13140/RG.2.1.3611.3445.
  • ACOUSTIC RADIATION FORCE IMPULSE IN HEPATITIS B VIRUS INACTIVE CARRIERS - A COMPARISON WITH OTHER CONDITIONS.
    G. Gherlan, P. Calistru, C. Voinea, C. Szabo
    EASL – The Liver Congress, Vienna, Austria, April 22 - 26, 2015, Journal of Hepatology 04/2015; 62 (2):S542. DOI:10.1016/S0168-8278(15)30807-2. ISSN 0168-8278.
  • THE AGREEMENT BETWEEN TRANSIENT ELASTOGRAPHY (TE) AND ACOUSTIC RADIATION FORCE IMPULSE IMAGING (ARFI).
    G. Gherlan, M. Neata, P. Calistru
    APASL 2016, Tokyo 20 - 24 February 2016, Hepatology International, February 2016, Volume 10, Supplement 1, pp S357, ISSN: 1936-0533 (Print) 1936-0541 (Online).
  • FIBROSCAN - ARE 10 VALID MEASUREMENTS MANDATORY ?,
    G. Gherlan, M. Neata, P. Calistru
    APASL 2016, Tokyo 20 - 24 February 2016, Hepatology International, February 2016, Volume 10, Supplement 1, pp S352- 353, ISSN: 1936-0533 (Print) 1936-0541 (Online).
  • NONINVASIVE CIRRHOSIS REGRESSION ASSESSMENT IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS FOR CHRONIC C HEPATITIS.
    G. Gherlan, M. Neata, P. Calistru
    APASL 2017, Shanghai, 15 - 19 February 2017, Hepatology Int, Vol 11, Issue 1, Feb 2017, ISSN: 1936-0533.
  • MONITORIZAREA PRIN METODE NEINVAZIVE A FIBROZEI LA PACIENTII CU HEPATITA CRONICA CU VHC TRATATI CU MEDICATIE CU ACTIUNE DIRECTA ANTIVIRALA.
    G. Gherlan, M. Neata, P. Calistru
    Conferinta Nationala de Boli Infectioase, 7 - 9 Iunie 2017, Timisoara – Prezentare orala.
  • RESULTS OF NUCLEOTIDE AND NUCLEOSIDE ANALOGUES TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B.
    G. Gherlan, A. Motoc, A. Culinescu, L. Filip, S. Lazar, D. Smadu, P. Calistru, S.A. Florescu, E. Ceausu
    APASL 2018, New Delhi 14 - 18 March, Hepatology International, March 2018, Volume 12, Issue 2 Supplement.
  • REZULTATELE TERAPIEI CU OMBITASVIR / PARITAPREVIR / RITONAVIR SI DASABUVIR LA PACIENTII TRATATI IN SPITALUL "DR. VICTOR BABES" IN PERIOADA 2017 / 2018.
    G. Gherlan, L. Filip, A. Culinescu, D. Obretin, S. Lazar, E. Ceausu, P. Calistru
    Conferinta Nationala de Boli Infectioase, Galati, 2018.
  • OUTCOMES OF RESPONSE GUIDED THERAPY WITH PEGYLATED INTERFERON ALPHA 2A IN CHRONIC HEPATITIS B AND D.
    G. Gherlan
    et al. Journal of Hepatology, Volume 70, Issue 1, e465, EASL – The Liver Congress, Vienna, Austria, April 10-14, 2019.

Articole publicate

  • EVALUATION OF LIVER FIBROSIS – INVASIVE OR NONIVASIVE METHODS.
    G. Gherlan, P. Calistru
    Revista Romana de Boli Infectioase, vol X, Nr. 4, 2007.
  • CONCORDANŢA CELOR MAI UTILIZATE METODE DE DIAGNOSTIC NEINVAZIV AL FIBROZEI HEPATICE ÎN HEPATITELE VIRALE CRONICE.
    G. Gherlan, P. Calistru, M. Neata, C. Voinea, C. Szabo
    REVISTA ROMÂNÅ DE BOLI INFECTIOASE – VOLUMUL XIV, NR. 4, AN 2011; 186-191 (B+).
  • FIBROSCAN – VARIABILITATEA NORMALA INTRE DOUA MASURATORI.
    G. Gherlan, P. Calistru, S. Lazar, M. Neata
    REVISTA ROMANA DE BOLI INFECTIOASE – VOLUMUL XV, NR. 4, AN 2012; 261-264 (B+).
  • DISTRIBUTIA GENOTIPURILOR HPV IN NEOPLAZIILE CERVICALE INTRAEPITELIALE - EXPERIENTA CENTRULUI DE DIAGNOSTIC SI TRATAMENT "DR. VICTOR BABES".
    C. Stefanescu, P. Calistru, C. Voinea, G. Gherlan
    REVISTA ROMANA DE BOLI INFECTIOASE, VOLUMUL XV, NR. 4, AN 2012; 261-264 (B+).
  • ULTRASOUND ELASTOGRAPHY IN CHRONIC VIRAL HEPATITIS – A REVIEW.
    G. Gherlan, P. Calistru
    REVISTA ROMANA DE BOLI INFECTIOASE, VOLUMUL XVII, NR. 3, AN 2014; 113-123 (B+).
  • THE INTRA-OBSERVER VARIABILITYOF ACOUSTIC RADIATION FORCE IMPULSE (ARFI) – IMPLICATIONS FOR THE USE OF THE METHOD IN MONITORING CHRONIC LIVER DISEASES.
    G. Gherlan, P. Calistru, C. Voinea, C. Szabo
    REVISTA ROMANA DE BOLI INFECTIOASE, VOLUMUL XVII, NR. 3, AN 2014; 140-146 (B+).
  • LIVER ULTRASOUND ELASTOGRAPHY : MORE THAN STAGING THE DISEASE.
    G. Gherlan
    World J Hepatol 2015; 7(12): 1595-1600
  • THE MANAGEMENT OF B HEPATITIS VIRUS INFECTION IN RELATION WITH HUMAN REPRODUCTION.
    G. Gherlan, P. Calistru
    ROMANIAN JOURNAL OF INFECTIOUS DISEASES, VOLUME XIX, NR. 3, 2016; 99-109 (B+).
  • PRIMARY HEPATIC MARGINAL ZONE LYMPHOMA IN A PATIENT WITH CHRONIC HEPATITIS C – A CASE REPORT.
    G. Gherlan, R. Stoia, M. Enyedi, C. Dobrea, P. Calistru
    MAEDICA – A JOURNAL OF CLINICAL MEDICINE, VOLUME 11, NR. 3, 2016; 250-254 (B+).
  • PSYCHIC STRESS IN C HEPATITIS VIRUS INFECTION.
    C. Boanca, M. Minulescu, G. Gherlan, P. Calistru
    REVISTA MEDICALA ROMANA, VOL LXIII, NR. 4, 2016; 286 – 290 (B+).
  • DEPREESION, MORTALITY AND SUICIDAL TRAITS OF INFECTED PATIENTS.
    C. Boanca, G. Gherlan, P. Calistru
    ROMANIAN JOURNAL LEGAL MEDICINE, Vol. 25, (1), 113, 109-112, Martie 2017
  • INFECTIOUS NEUROPATHIES.
    G. Gherlan
    ROMANIAN JOURNAL OF INFECTIOUS DISEASES, VOLUME XXI, NR. 1, 2018; 6-12 (B+).
  • LONG TERM FOLLOW UP AFTER HCV CURE WITH DIRECT ACTING ANTIVIRALS – REVIEW OF THE LITERATURE.
    A. Cazan, G. Gherlan, R. Dirtu, S.A. Florescu, A. Oprea, E. Ceausu, P. Calistru
    ROMANIAN JOURNAL OF INFECTIOUS DISEASES, VOLUME XXI, NR. 4, 2018; 167- 171 (B+, BDI).
  • INFLUENZA IN PREGNANT WOMEN.
    V. Melinte, G. Gherlan, A. Veja, E. Ceausu
    ROMANIAN JOURNAL OF INFECTIOUS DISEASES, VOLUME XXII, NR. 1, 2019; 6-14 (B+, BDI).
  • HEPATITIS C VIRUS - FROM UNKNOWN VIRUS TO A CURABLE DISEASE.
    R. Dirtu, A. Cazan, G. Gherlan, S.A. Florescu, E. Ceausu, P. Calistru
    ROMANIAN JOURNAL OF INFECTIOUS DISEASES, VOLUME XXII, NR. 2, 2019; 60-63 (B+, BDI).
  • COVID-19 IN A TERTIARY HOSPITAL FROM ROMANIA : EPIDEMIOLOGY, PREPAREDNESS AND CLINICAL CHALLENGES.
    C. Popescu, A. Marin, V. Melinte, G. Gherlan, F. Banicioiu, A. Dogaru, S. Smadu, A. Veja, E. Nedu, D. Stanciu, B. Voinescu, V. Simion, A. Toderan, A. Dascalu, C. Oprisan, G. Tardei, M. Nica, E. Ceausu, S. Ruta, S.A. Florescu
    TRAVEL MED INFECT DIS. 2020 May - Jun;35:101662. doi: 10.1016/j.tmaid.2020.101662. Epub 2020 Apr 10.

Carti publicate sau capitole in carti

  • 1. EVALUAREA FIBROZEI ÎN HEPATITELE CRONICE VIRALE
    George Sebastian Gherlan, Editura Amaltea 2018, ISBN 978-973-162-189-0,
  • HEPATITA ACUTĂ ŞI CRONICĂ CU VIRUSUL HEPATITIC C
    George Sebastian Gherlan, Petre Iacob Calistru, capitol în TRATAT DE BOLI INFECŢIOASE vol 1 sub redacţia Emanoil Ceauşu, Editura Medicală 2018, ISBN 978-973-39-0850-0
  • PERICARDITA INFECŢIOASĂ
    George Sebastian Gherlan, capitol în TRATAT DE BOLI INFECŢIOASE vol 1 sub redacţia Emanoil Ceauşu, Editura Medicală 2018, ISBN 978-973-39-0850-0.
  • MENINGITELE ACUTE VIRALE
    George Sebastian Gherlan, capitol în BOLI INFECŢIOASE, CURS PENTRU STUDENŢI ŞI MEDICI REZIDENŢI, VOLUMUL 1, 2019, sub redactia Adrian Streinu Cercel, Victoria Arama, Petre Iacob Calistru, ISBN: 978-606-011-063-7.
  • MENINGITA TUBERCULOASĂ
    George Sebastian Gherlan, capitol în BOLI INFECŢIOASE, CURS PENTRU STUDENŢI ŞI MEDICI REZIDENŢI, VOLUMUL 1, 2019, sub redactia Adrian Streinu Cercel, Victoria Arama, Petre Iacob Calistru, ISBN: 978-606-011-063-7.
  • ABCESELE CEREBRALE
    George Sebastian Gherlan, capitol în BOLI INFECŢIOASE, CURS PENTRU STUDENŢI ŞI MEDICI REZIDENŢI, VOLUMUL 1, 2019, sub redactia Adrian Streinu Cercel, Victoria Arama, Petre Iacob Calistru, ISBN: 978-606-011-063-7.
  • NEUROPATIILE INFECŢIOASE
    George Sebastian Gherlan, capitol în BOLI INFECŢIOASE, CURS PENTRU STUDENŢI ŞI MEDICI REZIDENŢI, VOLUMUL 1, 2019, sub redactia Adrian Streinu Cercel, Victoria Arama, Petre Iacob Calistru, ISBN: 978-606-011-063-7.
  • INFECŢII LA PACIENŢII ASPLENICI SAU CU HIPOSPLENISM
    George Sebastian Gherlan, capitol în TRATAT DE BOLI INFECŢIOASE vol 2 sub redacţia Emanoil Ceauşu, Editura Medicală 2020, ISBN 978-973-39-0847-0

Participări la studii clinice

  • A Multicentre, Randomised, Double-blind, Placebo-controlled, Parallel-group Phase II Study on the Efficacy and Safety of Debio 025 Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients, Debio 025-HCV-205 - 2009/2010 – Subinvestigator
  • Protocol 526H04 Randomized, Controlled Phase 2a/b Study of the Efficacy and Safety of PEG-rIL-29Administered in Combination with Ribavirin to Treatment-Naive Subjects with Chronic Hepatitis C Infection – 2010/2012 – Study Coordinator, Subinvestigator
  • Studiu clinic de faza IV al imunogenicitatii si rectogenitatii vaccinului gripal trivalent, inactivat preparat pentru sezonul 2010/2011 de INCDMI – Cantacuzino – Study Coordinator, Subinvestigator
  • A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase II Study on Efficacy and Safety of DEB025 Combined With Peg-IFN Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Relapsers and Non-responders to Previous Peg-IFN Alfa-2 Plus Ribavirin Treatment, CDEB025A2210, 2011/2013– Study Coordinator, Subinvestigator
  • A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of DEB025/Alisporivir in Combination With Peg-IFNα2a and Ribavirin in Hepatitis C Genotype 1 Treatment-naive, CDEB025A2301, 2011/2013 - Study Coordinator, Subinvestigator
  • Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in Which Peginterferon Lambda-1a (BMS-914143) Was Administered for the Treatment of Chronic Hepatitis C, AI452-016, 2012/2016 – Study Coordinator, Subinvestigator
  • A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Coadministration of ABT-450 with Ritonavir (ABT-450/r) and ABT-267 in Adults with Chronic Hepatitis C Virus Infection (PEARL-I), M13-393, 2012/2014 – Study coordinator, Subinvestigator
  • A Randomized, Open-Label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with and without Ribavirin Compared to Telaprevir Co-administered with Pegylated Interferon α-2a and Ribavirin in Treatment-Naive Adults with Chronic Hepatitis C Genotype 1 Virus Infection (MALACHITE I), M13 – 774, 2013/2015 – Subinvestigator
  • A multi-centre 3-year follow-up study to assess the durability of sustained virologic response in Alisporivir treated chronic Hepatitis C patients, CDEB025A2312, 2013/2016 - Study coordinator, Subinvestigator
  • A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir studies for chronic Hepatitis C patients, CDEB025A2313, 2013/2016 - Study coordinator, Subinvestigator
  • A phase 3, double-blind, multicentre, randomised, placebo-controlled study to determine the efficacy and safety of SPL7013 Gel (VivaGel®) to prevent the recurrence of bacterial vaginosis, SPL7013-018, 2015 – 2016 - Study coordinator, Subinvestigator
  • A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1), M13 – 590, 2016, Study coordinator, Subinvestigator
  • Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Romania, P 15 – 698, 2016/2017, Subinvestigator
  • A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) (VIOLET) VMT-VT-1161-CL-011, 2018 – continua, Study coordinator, Subinvestigator
  • A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized Subjects With Influenza A Infection who Are at Risk of Developing Complications (DIAMOND STUDY - 63623872FLZ3002), 2018 – suspended, Investigator Principal
  • A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole (200 mg, bid) for 10 days with vancomycin (125 mg, qid) for 10 days in the treatment of Clostridium difficile infection (CDI), 2019 – continua, Investigator Principal
  • A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR), 2019 – continua, Investigator Principal
  • A Multicenter, Open-label, Randomized Phase 2b Clinical Study to Assess Efficacy and Safety of Bulevirtide in Combination with Pegylated Interferon alfa-2a in Patients with Chronic Hepatitis Delta, MYR 204, 2019 - Investigator Principal

Proiecte susţinute de fonduri europene

  • Contract PN II-Parteneriate 42-094/2008: SINDROAME DIAREICE CAUZATE DE ENTEROBACTERIACEAE LA GRUPA DE VARSTA 0-4 ANI. STUDII MOLECULARE DE DIAGNOSTIC, PATOGENITATE, VIRULENTA SI ANTIBIOTICO-REZISTENTA – 2008/2011 – Participant
  • Contract 88/2012 PN-II-PT-PCCA-2011-3 INVESTIGAREA UNOR MARKERI VIRALI SI DE GAZDA CORELATI CU LIPSA DE RASPUNS LA TRATAMENTUL ANTI-VIRAL ÎN HEPATITA CRONICA CU VIRUS C” (HEPGEN) – 2012 – 2015 – Participant

Aptitudini si competente personale

 

Limba materna

Romana

Limbi straine cunoscute
Auto-evaluare
Nivel european (*)

Engleza
IntelegereVorbireScriere
AscultareCitireParticipare
la conversatie		Discurs oralScriere
C1C1B2B2C1

(*) Common European Framework of Reference (CERF) self-assessment grids

Competente si aptitudini organizationale

Capacitati de comunicare.
Persoana bine organizata si metodica.

Competente si cunostinte de utilizare a computerului

Cunoasterea functionarii computerului : foarte buna.

Permis de conducere

Categoria B din 1998

Informatii suplimentare

 

Membru al :

  • Asociatiei Europene pentru Studiul Ficatului (EASL)
  • Societatii Europene de Microbiologie Clinica si Boli Infectioase (ESCMID)
  • Societatii Romane de Boli Infectioase
  • Comitetului editorial al World Journal of Hepatology

Doctor GHERLAN George Sebastian

sus
Copyright © - Centrul Medical de Diagnostic si Tratament "Victor Babes"
Design
s-soft